NEWS
News & events
Our seminars
This is the calendar invitation to announce our speaker (details below) and share the “save-the-date”. ** 21/05/2026 - h. 14:00 speaker: Eleonora Leucci, Laboratory for RNA Cancer Biology, KU Leuven, Belgium title: Contribution of lncRNAs to the generation of drug-tolerant cells host: IEO-Bonaldi location: IFOM Conference Room ** https://gbiomed.kuleuven.be/english/research/50488876/54502087 Contribution of lncRNAs to the generation of drug-tolerant cells Eleonora Leucci1,*, 1Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. 2Trace, Leuven Cancer Institute, KU Leuven, Leuven, Belgium [email protected] Long non-coding RNAs (lncRNAs) generated from remote areas of the human genome constitute a major source of innovation for the adaptation to the numerous stresses encountered by cancer cells during progression and therapy resistance. As such, research in this field offers a unique opportunity to study cancer evolution and unveil novel biology. Over the years, we have characterised several novel transcripts affecting the generation of drug-tolerant cells. These transcripts represent previously unexplored cancer-specific vulnerabilities and thus extend the palette of therapeutic opportunities to include RNA-based medicines.
May 21, 2026
our last paper
Mechanisms of active wetting and fluidification in epithelial cell collectives.
Marchesi S, Guidolin C, Massey AE, Lemahieu G, Lavagnino Z, Beznoussenko GV, Mironov AA, Green BJ, Allievi E, Martini E, Magni S, Ghisleni A, Lomazzi C, Benvenuto AF, Schertel A, van Faassen DA, Fredd
Mar , 2026
Our ALLIANCES
Partners & Networks
Over the past 30 years since DEO’s founding, numerous scientists have launched and advanced their careers here. This has created a broad community of researchers who, despite being spread across institutes worldwide, still cherish their experiences at IEO and maintain strong ties to the department. In 2018, DEO held its inaugural Alumni meeting, bringing together 50 former PhD students, postdocs, and Group Leaders, now Principal Investigators or Institute Directors internationally, to reconnect and engage in scientific discussions.
READ
SUPPORT us
In Italy, taxpayers have the option to donate 0.5% of their taxes to non-profit organizations through the “Cinque per mille” (5x1000) scheme.
When submitting your income tax return via the 730 or CUD forms, you can designate 5x1000 of your tax to the European Institute of Oncology (IEO), helping to advance research, innovation, and treatment.